Bristol-Myers Squibb Co
F:BRM
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
Bristol-Myers Squibb Co
F:BRM
|
US |
|
D
|
Deere & Co
SWB:DCO
|
US |
|
E
|
Endo International PLC
F:EO7
|
IE |
|
D
|
DaVita Inc
DUS:TRL
|
US |
|
D
|
Darling Ingredients Inc
F:43D
|
US |
|
A
|
Ajinomoto Co Inc
XMUN:AJI
|
JP |
|
W
|
Wells Fargo & Co
XMUN:NWT
|
US |
|
C
|
Capital One Financial Corp
XMUN:CFX
|
US |
|
Essential Properties Realty Trust Inc
F:2OU
|
US |
|
O
|
Oversea-Chinese Banking Corporation Ltd
XMUN:OCBA
|
SG |
|
L
|
LSI Industries Inc
F:LS2
|
US |
|
D
|
Dental Corporation PCL
SET:D
|
TH |
|
V
|
Vertex Pharmaceuticals Inc
XMUN:VX1
|
US |
|
S
|
Surmodics Inc
F:SU6
|
US |
|
T
|
Thanapiriya PCL
SET:TNP
|
TH |
|
K
|
Koninklijke Philips NV
XMUN:PHI1
|
NL |
|
Old Mutual Ltd
F:2KS
|
ZA |
|
B
|
Basf Se
SIX:BAS
|
DE |
|
C
|
CF Industries Holdings Inc
XMUN:C4F
|
US |
|
T
|
Telkom Indonesia (Persero) Tbk PT
XMUN:TCID
|
ID |
|
F
|
FirstGroup PLC
F:FGR
|
UK |
|
L
|
Lam Research Corp
F:LAR
|
US |
|
Amper SA
F:APR
|
ES |
|
F
|
First Citizens BancShares Inc (Delaware)
F:FC6A
|
US |
Wall St Price Targets
BRM Price Targets Summary
Bristol-Myers Squibb Co
According to Wall Street analysts, the average 1-year price target for BRM is 53.74 EUR with a low forecast of 28.42 EUR and a high forecast of 66.95 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BRM's stock price target?
Price Target
53.74
EUR
According to Wall Street analysts, the average 1-year price target for BRM is 53.74 EUR with a low forecast of 28.42 EUR and a high forecast of 66.95 EUR.
What is the Revenue forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Revenue has been 8%. The projected CAGR for the next 8 years is -3%.
What is the Operating Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Operating Income has been 11%. The projected CAGR for the next 8 years is -3%.
What is the Net Income forecast for Bristol-Myers Squibb Co?
Projected CAGR
6%
Over the last 13 years, the compound annual growth rate for Net Income has been 10%. The projected CAGR for the next 8 years is 6%.
